Source: WHO (TobReg), February 2010The WHO tobacco Free Initiative announces the third volume of the WHO Study Group on tobacco Product Regulation (TobReg) Technical Report Series on the Scientific Basis of tobacco Product Regulation. This WHO Technical Report Series makes available the findings of an international group of experts that provide WHO with the latest scientific and technical advice in the area of product regulation.
From the actual document WHO Technical Report Series 955:
2.1 Preface
This Scientific Recommendation addresses electronic nicotine delivery systems (ENDS) designed for nicotine delivery to the respiratory system. [...]
This recommendation is being made because ENDS pose significant public health issues and raise questions for tobacco control policy and regulation. Manufacturers have not fully disclosed the chemicals used in ENDS; there are few data on their emissions or actual human exposure; their health effects have not been studied; and their marketing and use could undermine public smoking bans, which are important tobacco control interventions. The products could also undermine smoking cessation efforts by proposing unproven devices for smoking cessation in the place of products of proven efficacy. ENDS might also undermine the prevention of tobacco use because of their appearance and marketing as safe alternatives to tobacco products for nontobacco users, including children. [...]
4.1.1 Main recommendations
ENDS designed for direct nicotine delivery to the respiratory system fall into a regulatory gap in most countries, escaping regulation as drugs and avoiding the controls on tobacco products. There is currently insufficient evidence to assess whether ENDS products could be used to aid cessation, create or sustain addiction, or deliver constituents other than nicotine to smokers. Clinical trials, behavioural and psychological studies and post-marketing studies at individual and population levels are needed to answer these questions. Claims imputing health benefits, reduced harm or use in smoking cessation should be prohibited until they are scientifically proven. ENDS products should be regulated as nicotine delivery devices; when such regulation is not possible, they should be subjected under tobacco control laws to regulation of contents and labelling, prohibitions against public use and restrictions on advertising, promotion and sponsorship. [...]